A novel molecule plus rituximab was associated with higher response rates vs. rituximab alone, according to study data ...
UBS Global Biopharma Conference 2026 November 16, 2026 6:20 AM EST Hello. All right. Thank you, everyone, for coming today. My name is Dejia Zhang, and I'm on the UBS Investment Banking coverage team.
Everest Medicines raised HK$1.57B via a 2025 share placement, but its stock fell 63% by 2026 despite 142% revenue growth and ...
Travere Therapeutics has achieved two significant FDA approvals for FILSPARI, driving notable revenue growth. See why I rate ...
The RSUs vest over four years, with 25% of the shares vesting on each anniversary of the grant date, subject to the new ...
Detailed price information for Addus Homecare Corp (ADUS-Q) from The Globe and Mail including charting and trades.
Travere Therapeutics (NASDAQ: TVTX) is attempting to change the pattern via which rare kidney diseases are treated. The ...
Sibeprenlimab-szsi was associated with preserved kidney function vs. placebo at 2 years, according to study data presented at ...
Banking major HSBC will establish an artificial intelligence and emerging technology institute in Hong Kong in the first ...
Shares of Travere Therapeutics took a hit Tuesday, but closed in the green, after fewer than expected patients started taking its drug.
Live webcasts of the presentations will be accessible on the Investor page of Travere’s website at ir.travere.com/events-and-presentations. Replays will be ...